GLP-1 receptor agonists and methods of use

TW202635662APending Publication Date: 2026-09-01MERCK SHARP & DOHME CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114141466
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-08-29
Filing Date
2025-10-27
Publication Date
2026-09-01
Patent Text Reader

Abstract

The present invention relates to GLP-1 receptor agonists compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, n, p, A, X, Y and B are as defined herein. The present invention also relates to compositions which comprise a GLP-1 receptor agonist compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The invention further relates to methods for treating obesity or non-insulin-dependent diabetes mellitus (Type
Need to check novelty before this filing date? Find Prior Art